Session » (2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III
- 10:30AM-12:30PM
-
Abstract Number: 2494
Abatacept Reduces CD319+ (SLAM-F7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2492
Autoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2471
Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use
- 10:30AM-12:30PM
-
Abstract Number: 2476
Blinatumomab in rapid progressive systemic sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2487
Cardiovascular and venous thromboembolic events in systemic sclerosis: Epidemiological analysis of the Clinical Practice Research Datalink
- 10:30AM-12:30PM
-
Abstract Number: 2482
Characterizing Gastrointestinal Involvement in Systemic Sclerosis: Insights from the National Systemic sclerosis Progression INvestiGation (SPRING) Registry of the Italian Society of Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 2496
Comparing Long-term Outcome Across Systemic Sclerosis Subgroups Using a Multi-Organ Disease Progression Score
- 10:30AM-12:30PM
-
Abstract Number: 2499
Concomitant Anti-Ro/SSA Antibodies in Systemic Sclerosis Patients is Associated with Risks Beyond Dryness
- 10:30AM-12:30PM
-
Abstract Number: 2477
Current treatment Strategies in Systemic Sclerosis- Interstitial Lung Disease Patients: Real-World Insights from the EUSTAR Cohort (CP138)
- 10:30AM-12:30PM
-
Abstract Number: 2502
Deciphering Systemic Sclerosis Phenotypes: A Novel Approach Using Clustering Algorithms and Proteomic Insights. Results from the PRECISESADS Study
- 10:30AM-12:30PM
-
Abstract Number: 2472
Digesting the data: tracking gastro-intestinal manifestations in systemic sclerosis over time
- 10:30AM-12:30PM
-
Abstract Number: 2498
Effect of autologous myeloablative hematopoietic stem cell transplantation on skin and peripheral blood mononuclear cells in systemic sclerosis patients with interstitial lung disease
- 10:30AM-12:30PM
-
Abstract Number: 2488
Efficacy and Safety of Rituximab for Skin Involvement in Systemic Sclerosis: A Single-Center Study
- 10:30AM-12:30PM
-
Abstract Number: 2478
Endothelial Cell Biomarker Expression Suggests Increased Cell Adhesion in Juvenile SSc, Increased Cytokine Expression in JDM, and an Intermediate Phenotype in Overlap Syndrome Patients
- 10:30AM-12:30PM
-
Abstract Number: 2475
GERD Severity, Proton Pump Inhibitor Use, and Longitudinal Forced Vital Capacity in the CONQUER Registry
- 10:30AM-12:30PM
-
Abstract Number: 2500
Greater Economic Burden and Healthcare Resource Utilization in Patients with Systemic Sclerosis With Versus Without Interstitial Lung Disease: Results from a Systematic Literature Review
- 10:30AM-12:30PM
-
Abstract Number: 2491
High Prevalence of Autoimmunity and Cancer in Anti-NOR90-positive Patients: A Multicenter Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 2495
IL-6/STAT3 Signaling is Central for Chemokine Production in E2-Induced Dermal Inflammation
- 10:30AM-12:30PM
-
Abstract Number: 2470
Impaired Myocardial Flow Reserve on 82-Rubidium Positron Emission Tomography in Patients with Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2486
In vitro antifibrotic effects of nerandomilast on cell types relevant to intestinal remodeling and fibrosis in systemic sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2493
Investigating scoring systems to measure clinically relevant changes in systemic sclerosis-related finger acro-osteolysis over time, as assessed in serial hand radiographs
- 10:30AM-12:30PM
-
Abstract Number: 2483
Is There a Seasonal Variation in Raynaud’s Phenomenon Severity in Patients with Systemic Sclerosis?
- 10:30AM-12:30PM
-
Abstract Number: 2501
Microvascular dysfunction contributes to hand bone deterioration in SSc patients
- 10:30AM-12:30PM
-
Abstract Number: 2473
Nailfold Capillaroscopy Improves Cardiovascular Risk Stratification in Systemic Sclerosis: An Adjustment to the SCORE2 Algorithm
- 10:30AM-12:30PM
-
Abstract Number: 2484
Phenotype of systemic sclerosis patients with positive anti–NOR-90 antibodies
- 10:30AM-12:30PM
-
Abstract Number: 2481
Prevalence and Trends of Suicidal Ideation Among Hospitalized Adults with Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis (2016–2020)
- 10:30AM-12:30PM
-
Abstract Number: 2485
Prevalence of progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease
- 10:30AM-12:30PM
-
Abstract Number: 2479
REMS technology 5-y Imminent Fracture Risk in Systemic Sclerosis.
- 10:30AM-12:30PM
-
Abstract Number: 2480
Respiratory Muscle Weakness in a Systemic Sclerosis Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2490
Unmasking Mortality Risk: The Impact of Systemic Sclerosis in Stress-Induced Cardiomyopathy
- 10:30AM-12:30PM
-
Abstract Number: 2489
Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
- 10:30AM-12:30PM
-
Abstract Number: 2497
Unraveling the Complexity of Interferon Responses in Peripheral Blood Mononuclear Cells in Systemic Sclerosis at Single-Cell Resolution
- 10:30AM-12:30PM
-
Abstract Number: 2474
Unveiling the clinical spectrum of ACA-positive SSc-ILD: not as benign as expected